The TLR7 agonist induces tumor regression both by promoting CD4+T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells

Chenchen Wang(Nanjing University), Liping Su(Guangdong Provincial People's Hospital), Quan Zhou(Fujian Medical University), Bingya Liu(Shanghai Jiao Tong University), Xiaofeng Wang(China University of Mining and Technology), Xiongyan Wu(Ruijin Hospital), Xuehua Chen(Nanjing University of Chinese Medicine), Jianfang Li(Shanghai Jiao Tong University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention)
Oncotarget
December 15, 2014
Cited by 28


Related Papers